Atlas Trials

Phase I Study of Mitoxantrone Hydrochloride Liposome Injection

Clinical trial NCT02131688 · UNKNOWN

Trial details

NCT number
NCT02131688
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Malignant Lymphoma
Start date
2013-05-01
Primary completion
2015-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.